These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The anticoagulant effect of phenylindanedione in thromboembolic disorders. BROWN KW, MACMILLAN RL. Am J Med Sci; 1953 May 07; 225(5):495-500. PubMed ID: 13040333 [No Abstract] [Full Text] [Related]
27. Present status of anticoagulant therapy in the treatment of myocardial infarction; the use and misuse of anticoagulants; an evaluation of new anticoagulants, their indications and dosage. WRIGHT IS. Ann Intern Med; 1955 Nov 17; 43(5):942-54. PubMed ID: 13268990 [No Abstract] [Full Text] [Related]
30. [Heparin tolerance test and prothrombin time in the control of anticoagulant therapy of coronary infarction]. HOLLER G, WEINMANN O, HAMMERL H, ZEMANN J. Wien Klin Wochenschr; 1953 May 15; 65(20):402-4. PubMed ID: 13078388 [No Abstract] [Full Text] [Related]
39. The prevention of thromboembolic complications in myocardial infarction by anticoagulant therapy; a clinical-pathologic study. GLUECK HI, RYDER HW, WASSERMAN P. Circulation; 1956 Jun 15; 13(6):884-95. PubMed ID: 13356444 [No Abstract] [Full Text] [Related]
40. MYOCARDIAL INFARCTION DURING ANTICOAGULANT THERAPY: RELATION TO ANTICOAGULANT LEVEL TO PRESENCE OR ABSENCE OF RECENT CORONARY THROMBOSIS AT AUTOPSY. MOLNE K, HJORT PF. Acta Med Scand; 1965 May 15; 177():571-6. PubMed ID: 14297266 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]